Taiwan FDA registration 630bd1b44efa2fb3f454fddc5809a2c0
"100 first" insulin growth factor type 1 radioimmunoassay reagent
TW: “百首”類胰島素生長因子第一型放射免疫分析試劑
Taiwan·Risk Class 2·DIASOURCE IMMUNOASSAYS S.A.·Registered Dec 16, 2010 – Dec 16, 2025ExpiredRegistration details
- Analysis ID
- 630bd1b44efa2fb3f454fddc5809a2c0
- Customs Code
- DHAS0602192804
Company information
- Manufacturer
- DIASOURCE IMMUNOASSAYS S.A.
- Manufacturer Country
- Belgium
- Authorized Representative
- TAIWAN LIFE SUPPORT SYSTEMS INC.
Product details
- Intended Use
- Insulin growth factor type 1 radioimmunoassay reagent for in vitro quantitative detection of human serum
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.1370 Human Growth Hormone Testing System
- Import Information
- import
Dates and status
- Registration Date
- Dec 16, 2010
- Expiry Date
- Dec 16, 2025
About this record
Access comprehensive regulatory information for "100 first" insulin growth factor type 1 radioimmunoassay reagent in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 630bd1b44efa2fb3f454fddc5809a2c0 and manufactured by DIASOURCE IMMUNOASSAYS S.A.. The authorized representative in Taiwan is TAIWAN LIFE SUPPORT SYSTEMS INC..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices